Investigating the effect of phospholipids on droplet formation and surface property evolution in microfluidic devices for droplet interface bilayer (DIB) formation
Biomicrofluidics · 01.07.2022 · 16 (4)
DOI: 10.1063/5.0096193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomicrofluidics, online erschienen am 23.08.2022. Verfasst von Elanna B Stephenson und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering and Sciences, Tecnologico de Monterrey, Monterrey, Nuevo León, 64849, Mexico. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canada Research Chairs, Canada Foundation for Innovation, British Columbia Knowledge Development Fund.
Abstract (Originalsprache)
Despite growing interest in droplet microfluidic methods for droplet interface bilayer (DIB) formation, there is a dearth of information regarding how phospholipids impact device function. Limited characterization has been carried out for phospholipids, either computationally (in silico) or experimentally (in situ) in polydimethylsiloxane (PDMS) microfluidic devices, despite recent work providing a better understanding of how other surfactants behave in microfluidic systems. Hence, microfluidic device design for DIB applications relies heavily on trial and error, with many assumptions made about the impact of phospholipids on droplet formation and surface properties. Here, we examine the effects of phospholipids on interfacial tension, droplet formation, wetting, and hence device longevity, using DPhPC as the most widely used lipid for DIB formation. We use a customized COMSOL in silico model in comparison with in situ experimental data to establish that the stabilization of droplet formation seen when the lipid is dosed in the aqueous phase (lipid-in) or in the oil phase (lipid-out) is directly dependent on the effects of lipids on the device surface properties, rather than on how fast they coat the droplet. Furthermore, we establish a means to visually characterize surface property evolution in the presence of lipids and explore rates of device failure in the absence of lipid, lipid-out, and lipid-in. This first exploration of the effects of lipids on device function may serve to inform the design of microfluidic devices for DIB formation as well as to troubleshoot causes of device failure during microfluidic DIB experiments.
Autor:innen und Institutionen
- School of Engineering and Sciences, Tecnologico de Monterrey, Monterrey, Nuevo León, 64849, Mexico.
- Department of Chemistry, University of Victoria, Victoria BC V8P 5C2, Canada.
ORCID-Profile: Elanna B Stephenson, Sean Farley, John M Frostad, Katherine S Elvira
Förderung
- Canada Research Chairs
- Canada Foundation for Innovation
- British Columbia Knowledge Development Fund
- Michael Smith Foundation for Health Research
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Stephenson, E. B., García Ramírez, R., Farley, S., Adolph-Hammond, K., Lee, G., Frostad, J. M., & Elvira, K. S. (2022). Investigating the effect of phospholipids on droplet formation and surface property evolution in microfluidic devices for droplet interface bilayer (DIB) formation. Biomicrofluidics, 16(4). https://doi.org/10.1063/5.0096193
Vancouver
Stephenson EB, García Ramírez R, Farley S, Adolph-Hammond K, Lee G, Frostad JM, et al. Investigating the effect of phospholipids on droplet formation and surface property evolution in microfluidic devices for droplet interface bilayer (DIB) formation. Biomicrofluidics. 2022;16(4). doi:10.1063/5.0096193
BibTeX
@article{Stephenson2022,
author = {Stephenson, Elanna B and García Ramírez, Ricardo and Farley, Sean and Adolph-Hammond, Katherine and Lee, Gihyun and Frostad, John M and Elvira, Katherine S},
title = {Investigating the effect of phospholipids on droplet formation and surface property evolution in microfluidic devices for droplet interface bilayer (DIB) formation},
journal = {Biomicrofluidics},
year = {2022},
volume = {16},
number = {4},
doi = {10.1063/5.0096193}
}
EUVIMED